Article
The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC.
Current oncology (Toronto, Ont.) - 23 Jul 2026
Phillips William J, Leong Russell, Yeung Benjamin, Al Lawati Ahmed, Camidge D Ross, Lo Bryan, Wheatley-Price Paul
Abstract excerpt
Introduction: The prognostic significance of EGFR variant allele frequency (VAF) remains unclear in advanced EGFR-mutant (EGFR-mt) NSCLC. We examined the relationship of EGFR VAF and clinical outcomes in patients treated with first-line osimertinib. Methods: This retrospective cohort study evaluated patients with advanced EGFR-mt NSCLC treated at the Ottawa Hospital between July 2021 and June 2023. Baseline...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
